세계의 이식형 의료기기 시장 보고서(2025년)
Implantable Medical Devices Global Market Report 2025
상품코드 : 1769622
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

이식형 의료기기 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 6.3%로 성장할 전망이며, 1,403억 6,000만 달러로 성장이 예측됩니다. 예측 기간 동안 예상되는 성장은 생활 습관병 증가, 맞춤형 치료에 대한 수요 증가, 외래 수술 확대, 생체 적합 재료 채택 확대 등에 기인합니다. 예측 기간에 예상되는 주요 동향으로는 이식형 기기의 기술적 발전, 생체공학 임플란트의 연구개발의 진행, 스마트 임플란트 및 커넥티드 임플란트의 출현, 임플란트용 소형 전자기기의 혁신, 3D 프린팅과 커스텀 임플란트 설계에 대한 주목 증가 등이 있습니다.

저침습 수술에 대한 수요 증가가 향후 수년간 이식형 의료기기 시장 확대를 견인할 것으로 예측됩니다. 저침습 수술은 작은 절개와 개구부에서 수행되는 의료 개입으로 환자의 외상과 회복 시간을 최소화할 수 있습니다. 이러한 처치는 빠른 회복, 낮은 합병증 위험, 낮은 통증 감소, 작은 흉터 등의 이점이 있어 보다 안전하고 빠른 치료 선택을 원하는 환자들에게 매력적이기 때문에 수요가 높아지고 있습니다. 이식형 의료기기는 타깃을 좁힌 치료나 실시간 모니터링을 용이하게 함으로써 이러한 처치에서 중요한 역할을 하고 있습니다. 이식형 의료기기는 정확하고 개별화된 개입으로 치유의 신속화, 합병증 위험 감소, 장기적 전귀 개선에 기여합니다. 예를 들어 2024년 11월 미국을 거점으로 하는 비영리단체인 미국성형외과학회는 2023년 미용적 저침습 수술의 총 수가 2,544만 2,640건에 달했으며, 2022년 2,367만 2,269건에서 7% 증가했다고 보고했습니다. 이와 같이 저침습 외과 수술에 대한 수요 증가가 이식형 의료기기 시장의 성장을 촉진하고 있습니다.

이식형 의료기기 시장의 주요 기업은 치료효과 향상, 부작용 최소화, 개별화된 저침습 치료 옵션을 제공하기 위해 생체전기의료 분야 등 첨단기술의 개발 및 규제 당국의 승인 취득을 우선하고 있습니다. 생체전기의료는 전기신호를 이용하여 진단, 치료, 신경계의 자극을 실시하고, 건강 증진 및 다양한 증상의 관리를 실시하는 것입니다. 예를 들면, 2023년 7월, 미국의 바이오 테크놀로지 기업인 보스턴 사이언티픽 코퍼레이션은 미국 식품의약국(FDA)으로부터 Vercise Neural Navigator 5 소프트웨어의 승인을 받았습니다. Vercise Genus 뇌심부자극(DBS) 시스템과 병용함으로써, 이 소프트웨어는 파킨슨병이나 본태성 진전 환자의 치료에 있어 효율적인 프로그래밍을 위한 알기 쉽고 실용적인 데이터를 임상의에게 제공합니다. 보다 유연한 프로그래밍이 가능해지며, 각 환자 고유의 증상이나 요구사항에 맞는 맞춤형 치료 계획이 가능해집니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Implantable medical devices are instruments or apparatuses surgically inserted into the human body to monitor, support, or replace a biological function. These devices are intended to stay inside the body for extended durations, either temporarily or permanently, to assist in diagnosing, treating, or managing various medical conditions.

The primary types of implantable medical devices include cardiovascular implants, orthopedic implants, ophthalmology implants, dental implants, cochlear implants, microchip implants, and others. Cardiovascular implants are devices surgically placed to support, repair, or replace parts of the heart or blood vessels, such as stents, pacemakers, or artificial valves. These implants can be made from various biomaterials including ceramics, metals, polymers, and natural substances, and are used by end users like hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and more.

The implantable medical devices market research report is one of a series of new reports from The Business Research Company that provides implantable medical devices market statistics, including the implantable medical devices industry global market size, regional shares, competitors with the implantable medical devices market share, detailed implantable medical devices market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable medical devices industry. These implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable medical devices market size has grown strongly in recent years. It will grow from $103.16 billion in 2024 to $109.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an aging population, increased demand for minimally invasive surgeries, the expansion of healthcare infrastructure in developing countries, and higher healthcare spending.

The implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $140.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth anticipated during the forecast period can be attributed to the increasing incidence of lifestyle-related disorders, rising demand for personalized treatments, the expansion of outpatient surgical procedures, and the growing adoption of bio-compatible materials. Key trends expected in the forecast period include technological advancements in implantable devices, ongoing research and development in bioengineered implants, the emergence of smart and connected implants, innovations in miniaturized electronics for implants, and a heightened focus on 3D printing and custom implant design.

The growing demand for minimally invasive surgical procedures is expected to drive the expansion of the implantable medical devices market in the coming years. Minimally invasive procedures are medical interventions conducted through small incisions or openings, which help minimize patient trauma and recovery time. This demand is rising due to the benefits such procedures offer, including quicker recovery, lower risk of complications, reduced pain, and smaller scars, making them more attractive to patients seeking safer and faster treatment options. Implantable medical devices play a crucial role in these procedures by facilitating targeted therapy delivery and real-time monitoring. They contribute to faster healing, decreased complication risks, and improved long-term outcomes through precise and personalized interventions. For example, in November 2024, the American Society of Plastic Surgeons, a U.S.-based non-profit organization, reported that the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, reflecting a 7% rise from 23,672,269 in 2022. Thus, the increasing demand for minimally invasive surgical procedures is fueling the growth of the implantable medical devices market.

Leading companies in the implantable medical devices market are prioritizing the development of advanced technologies and obtaining regulatory approvals, such as those in the field of bioelectric medicine, to improve treatment effectiveness, minimize side effects, and deliver personalized, minimally invasive therapeutic options. Bioelectric medicine involves the use of electrical signals to diagnose, treat, or stimulate the nervous system to enhance health and manage various conditions. For example, in July 2023, Boston Scientific Corporation, a biotechnology company based in the U.S., received approval from the U.S. Food and Drug Administration (FDA) for its Vercise Neural Navigator 5 Software. When used in conjunction with the Vercise Genus deep brain stimulation (DBS) systems, this software offers clinicians straightforward and actionable data for efficient programming in the treatment of patients with Parkinson's disease or essential tremor. It allows for more flexible programming, enabling customized treatment plans tailored to each patient's specific symptoms and requirements.

In November 2024, Boston Scientific Corporation, a medical device company based in the U.S., acquired Axonics Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific seeks to strengthen its urology and pelvic health portfolio by incorporating Axonics' advanced sacral neuromodulation systems and Bulkamid urethral bulking agent, thereby providing improved treatment options for patients suffering from urinary and bowel dysfunction. Axonics Inc. is a U.S.-based medical technology firm specializing in implantable devices designed to treat urinary and bowel disorders.

Major players in the implantable medical devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Henry Schein Inc., Alcon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Terumo Medical Corporation, Smith & Nephew plc, W. L. Gore & Associates Inc., Edwards Lifesciences Corporation, Dentsply Sirona Inc., Demant A/S, Institut Straumann AG, Biotronik SE & Co. KG, Integra LifeSciences Holdings Corporation, Conmed Corporation, Globus Medical Inc., LivaNova Public Limited Company, MicroPort Scientific Corporation, B. Braun Melsungen Aktiengesellschaft.

North America was the largest region in the implantable medical devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable medical devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable medical devices market consists of sales of diagnostic implants, therapeutic implants, monitoring implants, and mechanical implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Medical Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for implantable medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable medical devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Implantable Medical Devices Market Characteristics

3. Implantable Medical Devices Market Trends And Strategies

4. Implantable Medical Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Implantable Medical Devices Growth Analysis And Strategic Analysis Framework

6. Implantable Medical Devices Market Segmentation

7. Implantable Medical Devices Market Regional And Country Analysis

8. Asia-Pacific Implantable Medical Devices Market

9. China Implantable Medical Devices Market

10. India Implantable Medical Devices Market

11. Japan Implantable Medical Devices Market

12. Australia Implantable Medical Devices Market

13. Indonesia Implantable Medical Devices Market

14. South Korea Implantable Medical Devices Market

15. Western Europe Implantable Medical Devices Market

16. UK Implantable Medical Devices Market

17. Germany Implantable Medical Devices Market

18. France Implantable Medical Devices Market

19. Italy Implantable Medical Devices Market

20. Spain Implantable Medical Devices Market

21. Eastern Europe Implantable Medical Devices Market

22. Russia Implantable Medical Devices Market

23. North America Implantable Medical Devices Market

24. USA Implantable Medical Devices Market

25. Canada Implantable Medical Devices Market

26. South America Implantable Medical Devices Market

27. Brazil Implantable Medical Devices Market

28. Middle East Implantable Medical Devices Market

29. Africa Implantable Medical Devices Market

30. Implantable Medical Devices Market Competitive Landscape And Company Profiles

31. Implantable Medical Devices Market Other Major And Innovative Companies

32. Global Implantable Medical Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Medical Devices Market

34. Recent Developments In The Implantable Medical Devices Market

35. Implantable Medical Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기